Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Patients”

549 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 549 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07193420
What this trial is testing

Reduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
GVHD - Graft-Versus-Host DiseaseHSCTHaploidentical Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 180
Testing effectiveness (Phase 2)Study completedNCT00551291
What this trial is testing

NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.

Who this might be right for
Myelodysplastic Syndromes
Hoffmann-La Roche 10
Post-approval studies (Phase 4)UnknownNCT04738955
What this trial is testing

Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors

Who this might be right for
Hematological Tumors Patients With High Risk Factors of Invasive Fungal Disease
Shandong Provincial Hospital 230
Not applicableLooking for participantsNCT06150469
What this trial is testing

Efficacy of Inhaled Aromatherapy on Nausea and Vomiting in Hematological Malignancies

Who this might be right for
Hematological Malignancies
University Hospital, Limoges 286
Post-approval studies (Phase 4)Study completedNCT02966457
What this trial is testing

DEcolonization in Patients With HAematological Malignancies (DEHAM)

Who this might be right for
Hematological Infection
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology 62
Not applicableUnknownNCT03288441
What this trial is testing

Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia

Who this might be right for
Hematologic NeoplasmsThrombocytopeniaAnticoagulants+1 more
Maastricht University Medical Center 300
Not applicableUnknownNCT04955977
What this trial is testing

Physical Exercise and Responses Measured by HIF-1 in COPD

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Universidad Nacional de Colombia 33
Not applicableStudy completedNCT04888286
What this trial is testing

DSAs in Patients Undergoing Allo-HSCT From Mismatched Donors

Who this might be right for
Hematologic DiseasesStem Cell Transplant Complications
Gruppo Italiano Trapianto di Midollo Osseo 912
Not applicableStudy completedNCT02447237
What this trial is testing

Randomized Trial:the Effect of Liquid Food on the Intake of Energy and Protein in Malignant Hematologic Patients

Who this might be right for
Hematological DiseaseDelayed Gastric EmptyingMalignant Disease
Jens Rikardt Andersen 20
Not applicableStudy completedNCT07462962
What this trial is testing

Effects of Mindfulness Meditation Training on Anxiety and Sleep Quality of Patients With Hematopoietic Stem Cell Transplantation During Admission in the Laminar Flow Chamber

Who this might be right for
Hematopoietic Stem Cell Transplantation (HSCT)Cancer and / or Hematological Malignancy
Henan University 70
Testing effectiveness (Phase 2)Looking for participantsNCT05537896
What this trial is testing

Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia

Who this might be right for
Hematological MalignancyNeutropenia
West Virginia University 55
Not applicableStudy completedNCT05260203
What this trial is testing

MargheRITA (Remote Intelligence for Therapeutic Adherence)

Who this might be right for
Multiple MyelomaSolitary PlasmacytomaAmyloidosis+11 more
Advice Pharma Group srl 124
Not applicableNot Yet RecruitingNCT06450821
What this trial is testing

PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications

Who this might be right for
OncologyPeriodontitisMyeloma+2 more
University of Leeds 60
Testing effectiveness (Phase 2)Ended earlyNCT00861965
What this trial is testing

Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match for Blood Cancers

Who this might be right for
Advanced or Refractory Leukemia, Lymphoma, Multiple Myeloma
Mirror Biologics, Inc. 2
Post-approval studies (Phase 4)Study completedNCT01198236
What this trial is testing

Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection

Who this might be right for
Invasive Fungal Infection
Zhejiang University 150
Not applicableNot Yet RecruitingNCT07162532
What this trial is testing

Clinico-hematological and Molecular Characteristics of Chronic Lymphocytic Leukemia Patients

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
Assiut University 45
Not applicableEnded earlyNCT01685411
What this trial is testing

Busulfan and Cyclophosphamide Followed By ALLO BMT

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 5
Testing effectiveness (Phase 2)Study completedNCT01221857
What this trial is testing

Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+2 more
Gamida Cell ltd 12
Not applicableUnknownNCT02612402
What this trial is testing

Effect of Smartphone App on Activity

Who this might be right for
Diabetes Type 2Hematologic Malignancy
Rambam Health Care Campus 270
Testing effectiveness (Phase 2)Study completedNCT00796068
What this trial is testing

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+4 more
Fred Hutchinson Cancer Center 130
Load More Results